Literature DB >> 11689521

Undescended testis and the risk of testicular cancer: importance of source and classification of exposure information.

A Stang1, W Ahrens, K Bromen, C Baumgardt-Elms, I Jahn, C Stegmaier, S Krege, K H Jöckel.   

Abstract

BACKGROUND: The strength of the association between undescended testis and testicular cancer varies considerably across studies. Here we report the effect of various classifications of self-reported history of undescended testis and different data sources on the estimates of the risk of testicular cancer from a case-control study.
METHODS: We performed a population-based case-control study including 269 testicular cancer cases and 797 controls matched on age and region. Medical history was assessed by interviews (index persons) and mailed questionnaires (mothers). We used conditional logistic regression to calculate odds ratios (OR) and kappa coefficients to assess agreement between different sources of information.
RESULTS: Odds ratios for testicular cancer ranged between 2.4 and 5.4 based on the sons' self-reports and between 1.1 and 1.9 based on the mothers' reports. The agreement between the sons and mothers on undescended, gliding or retractile testis was fair (kappa 0.53) and was good when these conditions were treated by surgery (kappa 0.89). The rating of a history of undescended testis by two urologists was fair (kappa 0.54).
CONCLUSIONS: The questionnaire design, the classifications of undescended testis and data sources have an important impact on the OR for the association of undescended testis and testicular cancer. These factors may partially explain the heterogeneity of the OR for this association in case-control studies relying on self-reports.

Entities:  

Mesh:

Year:  2001        PMID: 11689521     DOI: 10.1093/ije/30.5.1050

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  7 in total

Review 1.  Clinical epidemiology of testicular germ cell tumors.

Authors:  K-P Dieckmann; U Pichlmeier
Journal:  World J Urol       Date:  2004-03-18       Impact factor: 4.226

Review 2.  A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer--experiences of the son.

Authors:  Michael B Cook; Olof Akre; David Forman; M Patricia Madigan; Lorenzo Richiardi; Katherine A McGlynn
Journal:  Int J Epidemiol       Date:  2010-07-26       Impact factor: 7.196

Review 3.  Management of non-obstructive azoospermia.

Authors:  Koji Chiba; Noritoshi Enatsu; Masato Fujisawa
Journal:  Reprod Med Biol       Date:  2016-01-18

4.  Residential exposure to overhead high-voltage lines and the risk of testicular cancer: results of a population-based case-control study in Hamburg (Germany).

Authors:  Cornelia Baumgardt-Elms; Michael Schümann; Wolfgang Ahrens; Katja Bromen; Andreas Stang; Ingeborg Jahn; Christa Stegmaier; Karl-Heinz Jöckel
Journal:  Int Arch Occup Environ Health       Date:  2004-12-07       Impact factor: 3.015

5.  A population-based case-control study on social factors and risk of testicular germ cell tumours.

Authors:  Nils Schmeisser; David I Conway; Andreas Stang; Ingeborg Jahn; Christa Stegmaier; Cornelia Baumgardt-Elms; Karl-Heinz Jöckel; Thomas Behrens; Wolfgang Ahrens
Journal:  BMJ Open       Date:  2013-09-20       Impact factor: 2.692

6.  Cryptorchidism and testicular germ cell tumors: comprehensive meta-analysis reveals that association between these conditions diminished over time and is modified by clinical characteristics.

Authors:  Kimberly Banks; Ellenie Tuazon; Kiros Berhane; Chester J Koh; Roger E De Filippo; Andy Chang; Steve S Kim; Siamak Daneshmand; Carol Davis-Dao; Juan P Lewinger; Leslie Bernstein; Victoria K Cortessis
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-18       Impact factor: 5.555

7.  Risk of testicular germ-cell tumours in relation to childhood physical activity.

Authors:  M B Cook; Y Zhang; B I Graubard; M V Rubertone; R L Erickson; K A McGlynn
Journal:  Br J Cancer       Date:  2007-11-20       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.